Does DUVELISIB Cause Product dose omission? 10 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Product dose omission have been filed in association with DUVELISIB (COPIKTRA). This represents 1.3% of all adverse event reports for DUVELISIB.
10
Reports of Product dose omission with DUVELISIB
1.3%
of all DUVELISIB reports
2
Deaths
5
Hospitalizations
How Dangerous Is Product dose omission From DUVELISIB?
Of the 10 reports, 2 (20.0%) resulted in death, 5 (50.0%) required hospitalization.
Is Product dose omission Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DUVELISIB. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does DUVELISIB Cause?
Product use in unapproved indication (162)
Diarrhoea (110)
Death (89)
Fatigue (75)
Prescribed underdose (63)
Off label use (57)
Nausea (49)
Pneumonia (40)
Pyrexia (40)
Malignant neoplasm progression (38)
What Other Drugs Cause Product dose omission?
APREMILAST (4,567)
DUPILUMAB (2,729)
ALBUTEROL (1,742)
USTEKINUMAB (1,653)
INSULIN GLARGINE (1,500)
ETANERCEPT (1,400)
LENALIDOMIDE (1,400)
RUXOLITINIB (1,376)
ALIROCUMAB (1,354)
DIMETHYL (1,248)
Which DUVELISIB Alternatives Have Lower Product dose omission Risk?
DUVELISIB vs DYDROGESTERONE
DUVELISIB vs EBASTINE
DUVELISIB vs ECALLANTIDE
DUVELISIB vs ECONAZOLE
DUVELISIB vs ECULIZUMAB